No abstract available.
Hyperbilirubinemia, Neonatal*

No abstract available.
Hyperbilirubinemia, Neonatal*

No abstract available.
Hyperbilirubinemia, Neonatal*

No abstract available.
Hyperbilirubinemia, Neonatal*

No abstract available.
Hyperbilirubinemia, Neonatal* ; Phototherapy*

No abstract available.
Follow-Up Studies* ; Hyperbilirubinemia, Neonatal*

No abstract available.
Bilirubin* ; Fetal Blood* ; Hyperbilirubinemia, Neonatal*

Blue light has been widely used for the treatment of neonatal hyperbilirubinemia since the 1950s. Neonatal phototherapy can decrease plasma unconjugated bilirubin level, thus preventing bilirubin encephalopathy, and greatly reduces the exchange transfusion rate. Generally, it is accepted that the side effects of neonatal phototherapy are not serious and seem to be well controlled, however recent research has provided new evidence. The short-term side effects of phototherapy include interference with maternal-infant interaction, imbalance of thermal environment and water loss, electrolyte disturbance, bronze baby syndrome and circadian rhythm disorder. In addition, phototherapy may be associated with some long-term side effects such as melanocytic nevi and skin cancer, allergic diseases, patent ductus arteriosus and retinal damage. Therefore, it is necessary to develop evidence-based guidelines, new light devices and alternative agents, as well as individualized treatments, to minimize the side effects of phototherapy.
Evidence-Based Practice ; Humans ; Hyperbilirubinemia, Neonatal ; therapy ; Phototherapy ; adverse effects

AO bilirubinometer is a direct reading spectrophotometer specifically designed to measure total bilirubin using sera from newborn infantsl A study was performed to compare the bilirubin values obtained using the AO bilirubibometer and modified Diazo method(Rappaport method). The results were as follows : 1. The average percentage of recovery of AO bilirubinometer was 98.7%, while modified Diazo method was represented as 95.3%. 2. In comparison of two bilirubin techniques, the regression is linear, expressed by Y=1.16X-2.42, where values obtained as the bilirubinometer was on X axis and those from the modified Diazo mt\ethod on Y axis. The correlation coefficient was 0.95. 3. The variability of bilirubin values by cuvette was negligible, average percentage of variation coefficient being 0.1%. 4. The variability of bilirubin values by examiner was also negligible, the evarage percentage of bilirubin variation coefficient being 0.67%.
Axis, Cervical Vertebra ; Bilirubin ; Humans ; Hyperbilirubinemia, Neonatal* ; Infant, Newborn

PURPOSE: This study was designed to evaluate the efficacy of phototherapy for nonhemolytic hyperbilirubinemia in breast-fed and formula-fed infants and infants receiving formula and breast milk. METHODS: Full-term healthy infants with nonhemolytic hyperbilirubinemia (bilirubin concentration > or =13.0 mg/dL) were treated with conventional phototherapy by using daylight fluorescent lamps. Three groups of infants were studied : group A, formula-fed infants; group B, breast-fed infants; group C, infants receiving formula and breast milk. All patterns of feeding started at birth. Phototherapy was terminated only when bilirubin concentration had decreased to less than 10.0 mg/dL. RESULTS: A total of 163 infants were studied. Phototherapy was highly effective in reducing the bilirubin concentration in all three groups, however, its efficacy of in group B was poorer compared with the other two groups. The duration of photopherapy and weight loss during phototherapy were not significantly different in the three groups. Decrease rates of bilirubin concentration during phototherapy in group A and C were significantly faster than that of group B. CONCLUSION: The response to phototherapy of group B infants was significantly slower than those of group A and C infants. The addition of formula to the feedings for totally breast-fed infants, without suspension of breast feeding, would enhance the efficacy of phototherapy and reduce exposure time.
Bilirubin ; Breast Feeding ; Humans ; Hyperbilirubinemia* ; Hyperbilirubinemia, Neonatal ; Infant* ; Milk, Human ; Parturition ; Phototherapy* ; Weight Loss